Short Interest in Spectral Medical Inc. (OTCMKTS:EDTXF) Rises By 12.3%

Spectral Medical Inc. (OTCMKTS:EDTXFGet Free Report) saw a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 86,600 shares, a growth of 12.3% from the May 31st total of 77,100 shares. Based on an average daily trading volume, of 10,700 shares, the short-interest ratio is presently 8.1 days.

Spectral Medical Stock Up 7.6 %

Shares of Spectral Medical stock traded up $0.03 on Monday, reaching $0.38. The stock had a trading volume of 8,000 shares, compared to its average volume of 19,020. The stock has a market capitalization of $106.40 million, a P/E ratio of -7.05 and a beta of 0.93. Spectral Medical has a 1 year low of $0.22 and a 1 year high of $0.50. The company has a 50 day moving average price of $0.36 and a 200 day moving average price of $0.36.

Spectral Medical (OTCMKTS:EDTXFGet Free Report) last announced its quarterly earnings data on Monday, May 13th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.50 million for the quarter.

About Spectral Medical

(Get Free Report)

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.

Featured Stories

Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.